Clinical Trials Logo

Filter by:
NCT ID: NCT05447182 Completed - Clinical trials for Rheumatoid Arthritis

People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT)

PPM:RANT
Start date: July 6, 2021
Phase:
Study type: Observational

The investigators are interested in enrolling patients with rheumatoid arthritis (RA) who had a difficult time getting their disease under control even after trying multiple RA therapies. The investigators believe that there may be common patterns in the genes of this group of RA patients compared to those with more "textbook RA." Understanding genetic factors can help doctors to know in advance who may not respond to conventional therapies and start with treatments that work. Learning about underlying genes that influence treatment may help the investigators to identify new targets for therapy, to ultimately improve the lives of patients with RA and inflammatory arthritis.

NCT ID: NCT05447156 Completed - Clinical trials for Tobacco Use Disorder

QuitGuide for American Indians: Aims 2 & 3

Start date: December 14, 2022
Phase: N/A
Study type: Interventional

Aim 2: To assess the preliminary feasibility and acceptability of a tailored smoking cessation app prototype (here forward called tailored QuitGuide) among American Indian (AI) smokers. Aim 3: To test feasibility, acceptability, and preliminary efficacy of the tailored QuitGuide for smoking cessation among AIs.

NCT ID: NCT05447104 Completed - Saliva Altered Clinical Trials

Salivary Flow Promoted by Sugar-Free Chewing Gum

Start date: September 22, 2021
Phase: N/A
Study type: Interventional

This was a double-blind, single center in vivo salivary flow rate study. The objective was to compare a marketed sugar-free chewing gum to a clinically-tested sugar-free reference chewing gum, with regards to their ability to promote salivary flow during a 20-minute chew period in healthy human adult subjects. Two sugar-free chewing gums were randomly assigned and distributed in a cross-over fashion to study subjects over two test period visits. The primary response being measured was salivary flow promoted by sugar-free chewing gums during the 20-minute chewing period.

NCT ID: NCT05446909 Completed - Cognitive Decline Clinical Trials

Preventing Cognitive Decline

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.

NCT ID: NCT05446402 Completed - Acne Clinical Trials

Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

Start date: June 15, 2022
Phase: Phase 4
Study type: Interventional

The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.

NCT ID: NCT05446142 Completed - Healthy Clinical Trials

A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations

ERBA
Start date: July 1, 2022
Phase: Phase 1
Study type: Interventional

Relative bioavailability study to evaluate the pharmacokinetics of two new encorafenib formulations

NCT ID: NCT05446038 Completed - Anorexia Nervosa Clinical Trials

Multifamily Guided Self-Help Family-Based Treatment (MF-GSH-FBT)

MF-GSH-FBT
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This is a study testing whether an online Multifamily Guided Self-Help Family Based Treatment (FBT) for Anorexia Nervosa in adolescents aged 12 to 17 is acceptable and useful to families. This online Multifamily Guided Self-Help version of FBT consists of 12 weekly 60-minute telemedicine groups made up of parents from 4-5 families of young people with AN, coupled with access to an online guided self-help platform over the course of 6 months. The feasibility of online Guided Self-Help Family-Based Treatment for Anorexia is unknown, and the investigators hope to identify an adequate treatment for those who do not have access to in-person FBT.

NCT ID: NCT05445921 Completed - Anosmia Clinical Trials

Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction

Start date: September 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic olfactory dysfunction from the COVID-19 pandemic is a growing public health crisis with up to 1.2 million people in the Unites States affected. Olfactory dysfunction impacts one's quality of life significantly by decreasing the enjoyment of foods, creating environmental safety concerns, and affecting one's ability to perform certain jobs. Olfactory dysfunction is also an independent predictor of anxiety, depression, and even mortality. While the pandemic has increased the interest by the scientific community in combating the burgeoning health crisis, few effective treatments currently exist for olfactory dysfunction. Furthermore, patients impacted by "long COVID," or chronic symptoms after an acute COVID-19 infection, experience impairments other than olfactory and gustatory dysfunction, such as chronic dyspnea, impaired memory and concentration, and severe fatigue. These symptoms have been hypothesized to be a result of sympathetic positive feedback loops and dysautonomia. Stellate ganglion blocks have been proposed to treat this hyper-sympathetic activation by blocking the sympathetic neuronal firing and resetting the balance of the autonomic nervous system. Studies prior to the COVID-19 pandemic have supported a beneficial effect of stellate ganglion blocks on olfactory dysfunction, and recent news reports and a published case series have described a dramatic benefit in both olfactory function and other long COVID symptoms in patients receiving stellate ganglion blocks. Therefore, we propose a single cohort prospective study to generate pilot data on the efficacy and safety of sequential stellate ganglion blocks for the treatment of COVID-19-induced olfactory dysfunction and other long COVID symptoms.

NCT ID: NCT05445622 Completed - Healthy Clinical Trials

Assessing Student Learning of Spinal Mobilization With Real-time Objective Feedback

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

This is a research project on physical therapy education. Subjects will be recruited using convenience sampling from second-year physical therapy students on the campus of Youngstown State University. There are currently 28 students in the class. All students will be recruited to participate in the study. The objective of the study is to assess student learning of grades of spinal mobilization with real-time objective feedback.

NCT ID: NCT05445570 Completed - Colorectal Cancer Clinical Trials

Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages

NICE
Start date: May 13, 2022
Phase:
Study type: Observational

The NICE study is a prospective, multi-site study to train and validate a blood-based, glycoproteomic test for the early detection of advanced adenoma and colorectal cancer by collecting blood samples and associated relevant clinical information from average-risk participants who undergo routine screening colonoscopy as well as participants undergoing colonoscopy for surveillance or diagnostic indications